业界动态国内医卫资讯

NICE推荐PD-1抑制剂用于晚期肛门癌

Medscape News · 2026-11-12 23:13

摘要

NICE表示,英格兰约有250人可能受益于retifanlimab,该药现被推荐与化疗联合用于晚期肛门癌。Medscape News UK

English
NICE Recommends PD-1 Inhibitor for Advanced Anal Cancer

NICE said around 250 people in England could benefit from retifanlimab, now recommended with chemotherapy for advanced anal cancer. Medscape News UK

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界